Literature DB >> 10971784

Infections as a major preventable cause of human cancer.

H Kuper1, H O Adami, D Trichopoulos.   

Abstract

Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.

Entities:  

Mesh:

Year:  2000        PMID: 10971784     DOI: 10.1046/j.1365-2796.2000.00742.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  248 in total

Review 1.  The macrophage growth factor CSF-1 in mammary gland development and tumor progression.

Authors:  Elaine Y Lin; Valerie Gouon-Evans; Andrew V Nguyen; Jeffrey W Pollard
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 2.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

3.  XRCC1 and base excision repair balance in response to nitric oxide.

Authors:  James T Mutamba; David Svilar; Somsak Prasongtanakij; Xiao-Hong Wang; Ying-Chih Lin; Peter C Dedon; Robert W Sobol; Bevin P Engelward
Journal:  DNA Repair (Amst)       Date:  2011-10-29

4.  Clinical implication of serosal change in pathologic subserosa-limited gastric cancer.

Authors:  Joo Mee Kim; Hun Jung; Jun Suh Lee; Han Hong Lee; Kyo Yung Song; Cho Hyun Park; Myung Hae Jeon
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

Review 5.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

Review 6.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

7.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

Review 8.  Prostaglandins and cancer.

Authors:  D Wang; R N Dubois
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 9.  Inflammation and stem cells in gastrointestinal carcinogenesis.

Authors:  Michael Quante; Timothy Cragin Wang
Journal:  Physiology (Bethesda)       Date:  2008-12

Review 10.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.